DBV Technologies (DBVT) Change in Inventory (2020 - 2026)
DBV Technologies (DBVT) posted Change in Inventory of $2.6 million for Q2 2026, down 13.33% sequentially from $3.0 million in Q1 2026, and down 56.67% YoY from $6.0 million in Q2 2025.
DBV Technologies (DBVT) Change in Inventory (2020 - 2026) Analysis & Trends
DBV Technologies has reported Change in Inventory for 4 years, with the latest figure at $2.6 million in Q2 2026.
- Quarterly Change in Inventory fell 56.67% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.4 million (up 9.26% YoY) and the FY2025 annual result came in at $16.1 million, up 1057.2% from the prior year.
- Change in Inventory slipped to $2.6 million in Q2 2026 per DBVT's latest filing, from $3.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $6.0 million in Q2 2025 and troughed at $99000.0 in Q3 2024.
- A 3-year average of $2.9 million and a median of $2.8 million in 2026 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory soared 3567.68% in 2025, then slumped 56.67% in 2026.
- Over 3 years, Change in Inventory stood at $99000.0 in 2024, then jumped by 2052.53% to $2.1 million in 2025, then advanced by 22.01% to $2.6 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $2.6 million, $3.0 million, and $2.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.60 Mn |
| Jun 30, 2026 | 2.60 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Sep 30, 2024 | 99,000.00 |
| Sep 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2020 | -35,000.00 |
| Dec 31, 2020 | -35,000.00 |
| Sep 30, 2020 | -3.73 Mn |
| Sep 30, 2020 | -3.73 Mn |